Steen Hvitfeldt Poulsen

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis”.

Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis

New England Journal of Medicine(2023)10.1056/nejmoa2300757

N/A

5.3DataRank · unranked

317 citations

Parag Kale, Marianna Fontana, John L. Berk, Martha Grogan, Finn Gustafsson +32 more

Achievement of ESC/EAS LDL-C treatment goals after an acute coronary syndrome with statin and alirocumab

European Journal of Preventive Cardiology(2022)10.1093/eurjpc/zwac107

N/A

0.846DataRank · unranked

15 citations

Jennifer McGinniss, Philippe Gabríel Steg, Deepak L. Bhatt, Vera Bittner, Rafael Díaz +12 more

Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation

European Heart Journal - Cardiovascular Pharmacotherapy(2024)10.1093/ehjcvp/pvae025

N/A

0DataRank · unranked

24 citations

Philippe Gabríel Steg, Michael Szarek, Deepak L. Bhatt, Vera Bittner, Rafael Díaz +82 more

Electrocardiogram-based deep learning enables scalable screening of transthyretin amyloid cardiomyopathy

medRxiv(2024)10.1101/2024.09.30.24314651

N/A

0DataRank · unranked

4 citations

Evangelos K. Oikonomou, Rohan Khera, Ryan B. Choi, Sumukh V. Shankar, Robert M.A. van der Boon +21 more